Evidence map›Paper›PMID 34748815›Full record

ArticleJournal of virological methods2022

In vitro evaluation of the effect of mutations in primer binding sites on detection of SARS-CoV-2 by RT-qPCR.

Fee Zimmermann, Maria Urban, Christian Krüger, Mathias Walter, Roman Wölfel, Katrin Zwirglmaier

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Mutational Landscape of SARS-CoV-2.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fee ZimmermannBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany.
Maria UrbanBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany.
Christian KrügerBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany.
Mathias WalterBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany.
Roman WölfelBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany.
Katrin ZwirglmaierBundeswehr Institute of Microbiology, Neuherbergstr, 11, 80937, Munich, Germany. Electronic address: katrinzwirglmaier@bundeswehr.org.
Universität der Bundeswehr München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of RT-qPCR assays for the detection of SARS-CoV-2 have been published and are listed by the WHO as recommended assays. Furthermore, numerous commercial assays with undisclosed primer and probe sequences are on the market. As the SARS-CoV-2 pandemic progresses, the virus accrues mutations, which in some cases - as seen with the B.1.1.7 variant - can outperform and push back other strains of SARS-CoV-2. If mutations occur in primer or probe binding sites, this can impact RT-qPCR results and impede SARS-CoV-2 diagnostics. Here we tested the effect of primer mismatches on RT-qPCR performance in vitro using synthetic mismatch in vitro transcripts. The effects of the mismatches ranged from a shift in ct values from -0.13 to +7.61. Crucially, we found that a mismatch in the forward primer has a more detrimental effect for PCR performance than a mismatch in the reverse primer. Furthermore, we compared the performance of the original Charité RdRP primer set, which has several ambiguities, with a primer version without ambiguities and found that without ambiguities the ct values are ca. 3 ct lower. Finally, we investigated the shift in ct values observed with the Seegene Allplex kit with the B.1.1.7 SARS-CoV-2 variant and found a three-nucleotide mismatch in the forward primer of the N target.

Indexed as

COVID-19SARS-CoV-2Binding SitesHumansMutationRNA, ViralSensitivity and SpecificityRNA, ViralDiagnosticsPrimer mismatchRT-PCRSARS-CoV-2

Identifiers

PMID34748815
PMCPMC8570391
OpenAlexW3211980879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.